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ABSTrACT                        Next-Generation Sequencing (NGS) originally refers to high-throughput, massively 
parallel sequencing methods that allow the sequencing of up to billions of small (50-1000 bp), 
amplified DNA fragments at the same time but nowadays, there are NGS techniques that deter-
mine the sequence of long (up to 50 kbp) single molecules. Over the past years, NGS technolo-
gies become widely available with increasing throughput and decreasing sequencing costs per 
base making them more cost effective than the previously used capillary sequencing methods 
based on Sanger biochemistry. Nowadays, high-throughput DNA sequencing is routinely used 
on a wide range of important fields of biology and medicine enabling large-scale sequencing 
projects like analysis of complete genomes, disease association studies, whole transcriptomes, 
methylomes and provide new insights into complex biological systems. In addition, more and 
more NGS-based diagnostic tools are being introduced into the clinical practice, for example, 
on the fields of oncology, inherited and infectious diseases or pre-implantation and prenatal 
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The first-generation DNA sequencing
Although the structure of DNA was described in 1953 (Wat-
son and Crick 1953), it took more than 20 years to develop 
the first efficient method for sequencing DNA (Sanger and 
Coulson 1975). Before this work, several ad hoc methods in-
volving RNA synthesis and enzymatic digestion were used to 
determine some nucleotide sequences. In 1971, Wu was able 
to determine 12 nucleotides in the single-stranded cohesive 
ends of bacteriophage λ DNA. This method used radioactively 
labelled nucleotides, DNA polymerase, complex nucleotide 
digestion and chromatography (Wu and Taylor 1971). In 
1973, Gilbert and Maxam published a 24-bp sequence from 
Escherichia coli, by a method called wandering-spot analysis 
(Gilbert and Maxam 1973). Sanger used a short synthetic 
oligonucleotide primer, which hybridized to a single-stranded 
DNA template, DNA polymerase, and four radioactively 
labelled deoxyribonucleotide triphosphates (dATP, dCTP, 
dGTP, and dTTP) to generate newly synthetized DNA frag-
ments of different sizes. The sample was subdivided into 4 
different reaction mixtures; all of them contained only three 
of the four nucleotides, so the sequencing reactions were 
terminated at the missing nucleotides. After denaturation, 
the synthetized DNA fragments in the four samples were 
size-separated in polyacrylamide gel, and the sequence could 
be determined from radioautograph. This method was the 
first technique which allowed the sequencing of long DNA 
sequences and could be applied to any DNA molecule. The 
disadvantages of this method were the requirement for prior 
knowledge on the DNA sequence to which oligonucleotide 
primers would hybridize and the uneven distribution of the 
produced fragments with the desired lengths.
In 1977, dideoxynucleotide-triphosphates (ddNTPs lack-
ing the 3’ hydroxyl group) were introduced as “chain termina-
tors” (Sanger et al. 1977) and this first-generation technology 
dominated the DNA sequencing field for more than 30 years. 
In this approach, four separate sequencing reactions, each 
containing the four dNTPs (one of them was radioactively 
labelled) and one of the ddNTPs were set up and whenever 
a dideoxynucleotide was incorporated into the DNA by the 
DNA polymerase, the chain elongation stopped, thus, a mix-
ture of truncated fragments of varying lengths, all starting 
at the same primer and ending with the same base was pro-
duced. The fragments were size separated by poly-acrylamide 
gel electrophoresis at one nucleotide resolution and the 
sequence was deduced from the autoradiograms. The last 
major improvement was when fluorescent labelling replaced 
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the use of the expensive and hazardous radioactively labelled 
nucleotides (Smith et al. 1986). Based on the detection of the 
four fl uorescent dyes that were used for the labelling of the 
four ddNTPs was the fi rst commercial semiautomatic DNA 
sequencer developed by Applied Biosystems Inc. (ABI). 
This technology allowed sequencing in a single reaction. An 
incremental improvement was when capillary tubes replaced 
polyacrylamide gels which allowed more consistent results 
and also increased the speed of electrophoresis (Drossman et 
al. 1990). This fi rst-generation sequencing technology pro-
vided nearly all of the data for the Human Genome Project 
(International Human Genome Sequencing 2001; Venter et 




Commercially available second-generation sequencing tech-
nologies include the MiSeq, NextSeq, HiSeq systems of 
Illumina that use reversible dye terminator technique, the 
sequencing by ligation (SOLiD) and the semiconductor (Ion 
Torrent) technologies of Life Technologies as well as the py-
rosequencing based instruments (GS FLX, Junior) of Roche 
454 (Metzker 2010). Although the sequencing biochemistry 
used by these different sequencing platforms is diverse, the 
library preparation workfl ow is quite similar.
There are fundamental differences between the fi rst- and 
second-generation technologies:
(i) Maximum 96 clones can be sequenced at the same 
time in the fi rst-generation instruments while the sequence 
from up to billions of DNA fragments are determined in the 
second-generation sequencers;
(ii) One of the limitations of the fi rst-generation sequenc-
ing technologies in performing genome-wide investigations 
(such as genome or transcriptome sequencing) is the require-
ment for the cloning and thus, the amplifi cation of the target 
DNA fragments in bacterial hosts. This cloning step makes 
large scale sequencing projects manpower intensive and ex-
pensive, introduces biases and restricts the parallelism (Hall 
2007). In contrast, all second-generation technologies directly 
use mechanically or enzymatically fragmented nucleic acids 
to prepare sequencing libraries by adding forward and reverse 
sequencing adaptors (Fig. 1). The DNA fragments (genomic 
or complementary), i.e. the sequencing libraries are then 
clonally amplifi ed with the use of a single adaptor specifi c 
universal primer pair on a surface of streptavidin-coated 
DNA capture beads (Roche 454, SOLiD, Ion Torrent) or by 
‘bridge’ PCR on a solid array surface used by the Solexa 
technology (Illumina). The clonal amplifi cation method, fi rst 
used by the Roche 454 technology (Margulies et al. 2005), 
circumvented the cloning requirement but it also can insert 
bias into the results.
(iii) Whereas individual samples (sequencing reactions) 
in fi rst-generation sequencers is placed into lanes/capillaries 
and the sequence is determined by separating bases in space, 
second-generation sequencers rely on a huge number of 
nano-reactors containing amplifi ed clonal clusters of DNA 
fragments where the sequence of bases is resolved in time by 
implementing cyclic-array sequencing (Jarvie 2005). The pro-
cess is cyclic because in each sequencing cycle a single nucle-
otide or dinucleotide is investigated by an enzymatic process 
(synthesis or hybridization-ligation) to identify nucleotides in 
the template in a highly parallel way (Fig. 2 and 3).
The second-generation sequencing library preparation 
workfl ows are quite similar for the different sequencing plat-
forms while the sequencing biochemistries described in detail 
at the reviewing of the different technologies are diverse. 
These systems are capable to sequence samples from a wide 
variety of starting materials including genomic DNA, PCR 
products, yeast and bacterial artifi cial chromosomes (YACs, 
BACs), as well as cDNA or RNA. In general, DNA samples 
must be fragmented usually into small pieces (100-800 bp) or 
Figure 1. An overview of the steps of second-generation sequenc-
ing. The basic steps of the process are the same for each technology, 
diversifi cation can be observed at the clonal amplifi cation and cycle 
sequencing steps.
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larger (2-20 kbp) fragments for a special application, the mate 
pair library preparation for de novo genome sequencing (Fig. 
2). Adaptors (small nucleotide DNA sequences) are added to 
the ends of sample DNA that are necessary for subsequent 
steps including library amplification and quantification as 
well as sequencing. Specifically designed, oligonucleotide 
covered DNA Capture Beads (Roche 454, SOLiD, Ion Tor-
rent) or glass surface (Illumina) are used to immobilize single 
stranded library fragments via hybridization to one (Roche 
454, SOLiD, Ion Torrent) or both adaptors (Illumina). The 
ratio of the beads/surface and the fragments is adjusted in 
such a way that only one library fragment is bound on the 
majority of the beads (Roche 454, SOLiD, Ion Torrent) or the 
distance between the bound DNA fragments on the glass sur-
face is larger than the distance between the oligonucleotides 
holding a single fragment (Illumina), thus these ‘bridges’ do 
not cross each other. The bead-bound library is emulsified 
with amplification reagents in a water-in-oil mixture resulting 
in micro-reactors containing just one bead with one unique 
library fragment. Clonal amplification occurs in these mini-
reactors and the process is called emulsion PCR (emPCR), 
without contamination with other micro-reactors and DNA 
sequences. Similarly, the bound DNA fragments on the glass 
surface are amplified to a few hundred copies to form a cluster 
of identical DNA pieces. Beads from the emPCR are then 
enriched for template-positive beads by hybridization with 
capture beads and transferred either into micro-wells (Roche 
454, Ion Torrent) or chemically cross-linked to a glass slide 
(SOLiD). At the end, up to billions of parallel sequencing 
reactions are carried out at the same time using sequencing 
primers hybridized to universal adaptors at specific position 
and orientation maintaining strand specific information.
Roche 454 pyrosequencing technology
The pyrosequencing is based on a sequencing-by-synthesis 
method which allows sequencing of a single DNA strand 
by synthesizing the complementary DNA strand base by 
base from an oligonucleotide primer and detecting which 
base was actually incorporated into the DNA strand at each 
step (Metzker 2010). This technique uses four enzymes 
(DNA polymerase, ATP sulfurylase, luciferase and apyrase) 
and their substrates (dNTPs, adenosine-5´-phosphosulfate 
(APS), and luciferin). If the tested nucleoside triphosphate is 
incorporated by the sequencing polymerase, it results in the 
release of inorganic pyrophosphate (PPi) which is used for 
ATP synthesis by the ATP sulfurylase in the presence of APS. 
The production of ATP leads to the generation of a light burst 
that accompanies the ATP-dependent conversion of luciferin 
to oxiluciferin by the activity of the luciferase enzyme. This 
chemiluminescence of each picotiter well is detected and 
measured by a CCD camera and analyzed by the software. 
The apyrase degrades the unincorporated nucleotides and 
ATP and the next sequencing cycle can be started by adding 
the next nucleoside triphosphate. The sequence of the DNA 
template is determined from a “pyrogram” which shows 
the light intensities detected during the sequencing cycles. 
Theoretically, the intensity of the chemiluminescent light 
Figure 2. General steps of cycle sequencing by synthesis. In one step of a cycle, microreactors and chips containing the clonally amplified library 
fragments are flown with a (labeled) nucleotide followed by the detection of nucleotide incorporation. Next, the non-incorporated nucleotides 
and blockers are washed away. There four steps of a cycle corresponds to the four nucleotides of DNA.
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Figure 3. General steps (A) of cycle sequencing by ligation and (B) the interrogated bases in the different ligation cycles of the fi ve primer cycles. 
(A) In the fi rst step of a ligation cycle, a fl uorescently labeled oligonucleotide probe is ligated to the sequencing primer (1st cycle) or to the 
extended second strand (2nd to 15th cycles). The colour of fl uorescence depends on the fi rst two bases (denoted by X) of the probe. Each colour 
label four dinucleotides. After capping of the unextended strands, last three nucleotides (denoted by Z) with the fl uorophore are removed 
while three spacer nucleotides (denoted by N) retained in the growing DNA. After completion of the ligation cycles, the extended DNA strand 
is removed and another sequencing primer shifted with one nucleotide position is hybridized to the library fragment and ligation cycles begin. 
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produced should be proportional to the amount of the ATP, 
i.e. to the number of nucleotides incorporated from the tested 
one. However, the major limitation of the pyrosequencing 
approach is the homopolymeric sequence stretches because 
intensity of the generated light is easy to miscalibrate and the 
correct number of identical nucleotides cannot be determined. 
With the pyrosequencing technology a read length of 700 to 
1000 bp can be achieved which was the key advantage of the 
Roche platforms. For certain applications like de novo whole 
genome sequencing or de novo transcriptomics these long 
reads have been critical. The desktop (Junior) and production-
scale (FLX) systems of Roche are capable of generating 70 
and 700 Mb of sequence data, respectively. Roche recently 
announced the discontinuation of these platforms
Life Technologies Ion Torrent instrument: 
semiconductor sequencing 
This “sequencing by synthesis” technology differs from the 
other second-generation sequencing technologies in that no 
modified nucleotides, no optics and no cameras are used. 
Ion semiconductor sequencing is based on the detection of 
hydrogen ions that are released as by-products during nucle-
otide incorporation into the DNA strand by the polymerase 
(Metzker 2010). During each sequencing cycle the wells 
(which are basically miniature pH meters) of the semicon-
ductor chip containing DNA template-positive beads are 
sequentially flooded with a single species of the four different 
(A, T, G, C) deoxyribonucleotide triphosphates. If the intro-
duced deoxyribonucleotide triphosphates incorporated into 
the growing template strand, the released proton changes the 
pH of the solution which can be detected by the proprietary 
ion sensor of the corresponding well of the semiconductor 
chip. If two identical bases are incorporated into the DNA 
strand, the voltage will be double, and the chip will record two 
identical bases. If there is no deoxyribonucleotide triphos-
phate incorporation, no voltage change will be detected. In 
case of homopolymer repeats multiple deoxyribonucleotide 
triphosphate molecules will be incorporated in a single cycle 
and this leads to a corresponding number of released protons 
and a proportionally higher electronic signal. The unattached 
dNTP molecules are washed away before the next cycle and 
a different dNTP species is introduced. The major benefits 
of Ion Torrent semiconductor sequencing are rapid sequenc-
ing speed and low operating costs due to the avoidance of 
modified nucleotides and optical measurements. The system 
has the same limitation as pyrosequencing, i.e. the accurate 
detection of long homopolymer repeats. Currently, Life 
Technologies distributes two desktop sequencers of different 
throughput, the Personal Genome Machine (PGM) and the 
Proton which can produce up to 2 and 10 Gbp sequence data, 
respectively. The main advantages of the Ion Torrent systems 
are the short sequencing time (2-4 hours) and the scalability 
which is achieved with the use of chips that have different 
numbers of minireactors.
The reversible dye terminator sequencing: the 
Illumina/Solexa Technology 
The Illumina/Solexa technology is unique among the second-
generation sequencing methods that both clonal amplification 
of the library fragments and sequencing (also by synthesis) 
is performed on the solid surface of the flow cells (Metzker 
2010). Because of the sequencing chemistry, i.e. the use of 
nucleotides labeled with four different cleavable fluorescent 
dyes and reversibly blocked on the 3’ C-atom, the DNA poly-
merase can incorporate only a single nucleotide, thus, this 
system does not suffer from the presence of homopolymeric 
stretches. At present, the majority of the Illumina instruments 
support the sequencing of 2 x 125 or 2 x 150 nucleotides; 
however, the MiSeq machine is capable of reading 2 x 300 
nucleotides in paired-end mode. The read lengths are limited 
because of signal decay and de-phasing caused by incomplete 
cleavage of fluorescent modification or the 3’ terminating 
moiety. Currently, the portfolio of Illumina has the sequenc-
ing power for every scale: The desktop sequencers MiSeq 
and NextSeq can provide up to 15 and 120 Gbp sequence 
data per run, respectively, allowing targeted or even whole 
genome sequencing. Using the HiSeq series instruments, 4-6 
billion reads, 1-1.8 Tbp sequence can be obtained in a single 
run that enable researchers to perform large-scale sequenc-
ing projects. The HiSeq X Ten system contains ten HiSeq X 
instruments and is designed for population-scale projects to 
sequence thousands of human genomes. 
Sequencing by ligation: the SOLiD system of Life 
Technologies
Unlike the other three second-generation methods that are 
based on sequencing by synthesis, the SOLiD (Sequenc-
ing by Oligonucleotide Ligation and Detection) technology 
developed by Life Technologies uses hybridization-ligation 
cycles (Fig. 3) (Metzker 2010). In the first primer cycle, Uni-
versal seq primer (n) attaches to the P1 adaptor of the clonally 
amplified library fragments. During the first ligation cycle, 
16 dinucleotide probes labelled by four different fluorescent 
dyes (each dye label four dinucleotides) and containing a 
three-nucleotide long non-specific spacer are used to inter-
rogate the 1st and 2nd positions of the fragment and the probe 
with complementary dinucleotide is ligated to the primer. 
After imaging of the fluorescence, the unextended strands are 
capped with the same mixture of nonfluorescent probes and 
treated with phosphatase to prevent any unextended strands 
for contributing to “out of phase” ligation events. Finally, the 
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fl uorescent label is removed and the second ligation cycle to 
interrogate the 6th and 7th position of the fragment may start. 
After 7, 10 or 15 ligation cycles are performed, the extension 
product is removed and the template is reset with a primer 
complementary to the n-1 position for the second round of 
ligation cycles. Altogether, fi ve primer cycles with the same 
number of ligation cycles are completed to obtain 35, 50 
or 75 nucleotide long sequence reads from the fragments. 
Through the primer reset process, each base is interrogated 
in two independent ligation reactions by two different prim-
ers which enable the distinction between a sequencing error 
and a sequence polymorphism. The SOLiD 5500 Wildfi re 
instrument is capable of producing 320 Gb of sequence data 
per run from 3.2 billion 2 x 50 bp paired-end reads.
Third-generation sequencing technologies
Despite the obvious advantages of the second-generation 
sequencing (such as extremely high throughput, low cost 
per nucleotide sequenced), there are some weaknesses re-
lated to these techniques. For example, the PCR steps during 
library preparation may introduce biases such as introducing 
“mutations” because of the lack of proof-reading or over-
representation of certain fragments. The lower than 100% 
effi ciency of the different steps during the alternating phases 
of nucleotide incorporation, signal detection and signal re-
moval may lead to dephasing (reading not only the nth but also 
the (n-1)th nucleotide in the clonal population) which results 
in the decrease of read quality towards the end. One other 
major disadvantage of the second-generation sequencing 
techniques is the read length which is usually shorter than 
the one obtained in fi rst-generation Sanger sequencing which 
is capable yielding routinely ~1000-1200 nucleotide long 
sequences. The longest second-generation reads are obtained 
by Roche 454 pyrosequencing are comparable to those of 
the fi rst-generation sequencers (700-1000 nucleotide), how-
ever, the other systems produce much shorter reads of 35-75 
(SOLiD), 300 (Illumina) and 400 (Ion Torrent) nucleotide 
length. Short reads cause diffi culties for the assembly of 
genomes that contain repetitive sequences which is the case 
for most organisms. Recent improvements like mate-paired 
or paired-end sequencing make the “de novo” assembly of 
high-quality genomes possible. However, the genome of only 
a limited number of eukaryotic species has been completely 
sequenced due to the limitations of second-generation se-
quencing technologies including biases resulting from base 
compositions and the inability to sequence through large 
repeated elements. 
On the rapidly growing fi eld of next-generation sequenc-
ing technologies, the third generation platforms can overcome 
the limitations of the current sequencing techniques. Today, 
Pacifi c Biosciences and Oxford Nanopore provide single-
molecule, real-time (SMRT) sequencing systems which 
achieve extra-long reads (up to 50 kbp) with high consensus 
accuracy that simplify and improve genome assembly. As the 
simplifi ed library construction does not require amplifi cation 
steps, no PCR biases and errors are introduced. In addition, as 
only one DNA molecule is read during the sequencing, errors 
from dephasing are not a problem. Though the accuracy of the 
raw reads are lower compared to data from second-generation 
sequencers, sequencing the same template molecule more 
than once and construction of consensus read sequences can 
provide high quality sequences. These technologies even 
allow the recognition of different base modifi cations (such 
as methylation on adenine and cytosine residues) directly 
without the use of chemical modifi cations, thus, allowing 
high-resolution mapping of the epigenome. In addition, RNA 
molecules without conversion into complementary DNA can 
be directly sequenced.
The library preparation for the third-generation sequenc-
ers includes the fragmentation and end-repairing of DNA 
which is followed by the ligation of hairpin sequences to both 
(Pacifi c Biosciences) or one (Oxford Nanopore) end of the 
fragments. Before starting the sequencing, an oligonucleotide 
primer is added (Pacifi c Biosciences) and a polymerase is 
bound to the DNA. Note that there is no PCR amplifi cation 
step in this process that could introduce bias (Fig. 4).
Figure 4. An overview of the steps of third-generation sequencing. 
Single molecule sequencing does not require PCR amplifi cation after 
library preparation.
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Single molecule real-time sequencing
Single molecule real-time (SMRT) sequencing is a paral-
lelized single molecule DNA “sequencing”-by-synthesis” 
technology developed by Pacific Biosciences (Metzker 2010). 
The technology based on direct observation of DNA synthesis 
of single DNA molecules in real-time in ~75000 zero-mode 
waveguides (ZMWs) placed onto a SMRT chip (Levene et 
al. 2003). The ZMW is cylindrical hole which is ~70 nm in 
diameter “drilled” into a 100 nm thin metal film supported by 
a transparent glass/silica substrate. As the wavelength of the 
laser light used for illumination is larger than the diameter of 
the ZMW, the light cannot pass through the ZMW’s aperture, 
rather it decays exponentially inside the chamber (Metzker 
2010) and only penetrates the lower 20-30 nm of the wave-
guide creating a detection volume of ~20 zeptoliters (2 x 10− 21 
liters). A single DNA polymerase molecule is attached to the 
bottom of each ZMW which synthesizes the DNA using 4 
dNTPs that are labelled fluorescently with 4 different dyes on 
the γ-phosphate and not on the bases as the nucleotides used 
in first- and second-generation sequencing. The background 
signal from the fluorescently labelled nucleotides is very low 
because they diffuse through the illuminated part of the ZMW 
very quickly. However, when the DNA polymerase on the bot-
tom of the ZMW incorporates a nucleotide, the enzyme holds 
it in the detection volume for tens of milliseconds which is 
orders of magnitude longer than the average time the diffus-
ing nucleotides spend there. The presence of the nucleotide 
in the detection volume for so long creates a bright fluores-
cence pulse which can be distinguished from the background. 
After the nucleotide incorporated, the pyrophosphate with 
the fluorescent dye is released and quickly diffuses from the 
detection volume and the background level fluorescence is 
restored. The base call is made according to the correspond-
ing fluorescence of the dye. Typical synthesis rates in SMRT 
sequencing are 1-3 bases per second (Korlach et al. 2010). 
The fluorescent signal is not only characterized by the emis-
sion spectra but also by its duration and the interval between 
the signals defined as pulse width and interpulse duration 
(IPD), respectively, which give information about the kinet-
ics of the polymerase. The presence of modified nucleotides 
alters polymerase kinetics and therefore enables the detection 
of many types of DNA base modifications (e.g., methylation 
or hydroxymethylation) which is one of the great advantages 
of this technology (Flusberg et al. 2010). Although the ac-
curacy of the base calling using this approach is lower than 
with the second-generation methods, good quality sequence 
can be generated by sequencing the same template more 
than once and on both strand during the run and generating a 
consensus read sequence from the multiple alignment of all 
the sequences from each template. The possibility to sequence 
both strand of the template more than once is provided by the 
special structure of the library fragments, called SMRTbells. 
Both end of the DNA fragments are ligated to a hairpin which 
makes the DNA structurally linear but topologically circular, 
thus, a strand displacing DNA polymerase will use each posi-
tion of the circle as template several times. In the case reverse 
transcriptase is used for sequencing, RNA molecules can be 
sequenced directly, without the need of cDNA construction. 
Currently, the PacBio RS II system provides an average read 
lengths of more than 10 kbp where the longest reads are more 
than 40 kbp when a library with average fragment length of 
20 kb is used.
Nanopore sequencing
Nanopore sensing developed by Oxford Nanopore is an 
emerging technology which can be used for the detection and 
identification of a wide range of molecules such as to distin-
guish the four bases of nucleic acids or to measure protein or 
ligand concentration (Clarke et al. 2009). The technology re-
lies on the fact that applying voltage across a nanopore seated 
in an electrically insulating membrane an electric current can 
be observed. If single nucleotides, strands of DNA or other 
molecules pass through the pore, the ionic current is disrupted 
and it can create a characteristic change in the magnitude of 
the current and enables a direct reading, for example, of the 
DNA sequence. A nanopore is simply a hole of few nano-
meters in diameter which can be formed, for example, by 
proteins like alpha-haemolysin in lipid bilayer membranes 
or by solid-state materials in synthetic membranes created 
from graphene or silicon or by a pore-forming protein seated 
in synthetic material. An Oxford Nanopore device is a sensor 
array chip which contains tens of thousands of micro wells 
each of them containing a nanopore and its own electrode. For 
DNA strand sequencing, DNA is fragmented, then a hairpin is 
ligated to one end of a fragment and a processive enzyme is 
bound to the free fragment end. The enzyme associates with 
the pore forming protein, unzips the double stranded DNA 
and threads one strand through the nanopore and individual 
DNA bases on the strand are identified in sequence as the 
DNA molecule passes through. The presence of the hairpin 
ensures that the complementary strand is sequenced, too. By 
using a processive enzyme specific for RNA and adapting 
the nanopore to distinguish RNA-specific bases, it is possible 
to analyze the original sample RNA strand directly, without 
converting it into cDNA. 
Application of Next-Generation Sequencing 
in biomarker discovery
The growth, development and maintenance of an entire organ-
ism as well as its responses to the changes of the environment 
and to biotic and abiotic stresses are directed by its genes, 
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their expression and their interactions. The NGS technology 
made genome sequencing of any organism affordable and fea-
sible as well as enables genome-wide investigation of varia-
tions between individuals, organs, tissues, cells and between 
different environmental and physiological conditions.
Next-generation sequencing applications include de novo 
or re-sequencing of whole genomes, targeted sequencing of 
genomic regions of interest, transcriptome and small RNA 
sequencing as well as genome-wide mapping of DNA methy-
lation or DNA-protein interactions. In addition, the species 
composition and coding potential of microbial populations 
can be assessed with the help of NGS.
Genome sequencing 
The goal of genome sequencing in the first place is to de-
termine the gene content and to assemble the reference ge-
nome of the organism studied then to identify those genetic 
variations that lead, for example, to better performance, to 
higher virulence, to resistance to pathogens or to disease 
susceptibility.
Whole genome sequencing
In de novo whole genome sequencing the genome is se-
quenced and assembled without using direct comparison 
against a known sequence. After assembling this reference 
genome sequence, it is possible to perform comparative 
sequencing or whole genome re-sequencing of other individu-
als of the same species or tissues with genetic abnormalities 
(such as cancer) to identify polymorphisms, mutations, and 
structural variations.
A de novo genome sequence is always assembled from 
much shorter reads (50 to 20000 bp) than itself (from kbp to 
several Gbp). These reads are compared to each other, and 
the overlapping regions are used to build longer contiguous 
sequences called contigs. Then scaffolds can be built from 
neighboring contigs separated by gaps of unknown length 
(Ekblom and Wolf 2014). Ideally, a genome assembly should 
deliver end-to-end chromosomal sequences but repeat re-
gions and polyploidy can provide real challenges for whole 
genome sequencing. Repeated sequences, such as transpos-
able elements or the genes coding for the ribosomal RNA 
(rDNA) precursor, are distributed throughout the genome. 
Thus, the shorter reads from these elements can be aligned 
to many possible regions in the genome and the order of the 
flanking sequences, i.e. the non-repetitive sequences cannot 
be determined. To overcome this problem and to increase 
mapping specificity a method called “mate-paired” sequenc-
ing is used (Wetzel et al. 2011). Mate-pairs are reads that 
are originated from the two ends of the same genomic DNA 
fragment which is typically 1-3 kbp in length but can be as 
long as 20 kbp. During library preparation adaptors/labels are 
added to the ends of the fragmented genomic DNA which is 
then size-selected and the DNA fragments are circularized. 
The non-circularized DNA fragments are removed by diges-
tion and the circular DNA is fragmented and affinity purified. 
Finally, the sequencing adaptors are added. For the assembly 
of most bacterial genomes, current read lengths, accuracy and 
mate-paired libraries of second-generation technologies are 
already sufficient to obtain very few contigs (Hunyadkurti et 
al. 2011). In contrast, the more complex genome of higher 
eukaryotes, that may contain as long repeats as the members 
of the Ogre retrotransposon family reaching 25 kb in size 
(Macas and Neumann 2007), requires other approaches, such 
as the use of third generation sequencers. Plants in particular 
provide challenges for genome sequencing. Many plants are 
polyploid and therefore can have more than two copies of 
chromosomes. For example, the bread wheat (Triticum aes-
tivum) is hexaploid, more precisely, with three very similar, 
complete diploid genome sets termed A, B and D or the com-
mercial strawberry (Fragaria x ananassa) which is octoploid 
offering real difficulties for genome assembly (Marx 2013). 
Whole genome assembly of polyploid genomes with only 
short sequence reads is impossible because it is not known to 
which chromosome the short read belongs. The combination 
of third-generation and mate-paired sequencing to create scaf-
folds and short read sequencing to provide sequencing depth 
may solve the problem to assemble polyploid genomes.
The reference sequence describes usually the genome of 
a single individual or in the case of the human genome, of a 
very few individuals and provides the foundation of genetic 
studies, however, it cannot explain in itself the phenotypic 
variations that can be observed in the population. Genetic 
variations in other individuals on the sequence level can be 
discovered with re-sequencing of their genome. Usually, 
high-throughput second-generation techniques providing 
short reads are used for whole genome re-sequencing to detect 
single nucleotide polymorphisms (SNPs) and small insertions 
and deletions (InDels). The employment of third-generation 
technologies and sequencing of second-generation mate-
paired libraries facilitates the recognition of larger insertions 
and structural rearrangements such as translocations.
One of the greatest achievements of mankind was the 
sequencing of the reference copy of the human genome 15 
years ago (International Human Genome Sequencing 2001; 
Venter et al. 2001), which created the basis for coping with 
the big challenge to identify those genomic regions and genes 
that are responsible for the numerous traits of medical im-
portance, such as driving mutations in cancer, susceptibility 
to certain diseases or response to drug treatment. There are 
over 10000 so-called single-gene/monogenic diseases that 
are known to be determined by the not proper functioning 
of a single protein resulting from modifications or a single 
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error in the coding gene. Lots of diseases are caused by the 
complex interactions of more than one gene and have strong 
genetic component in addition to the environmental influ-
ences. Genetic experiments in humans are not allowed by 
ethical reasons, that is why the identification of the genetic 
determinants of diseases is attempted and facilitated via re-
sequencing based methods such as comparing the genome of 
normal and tumor cells, investigating family pedigrees and 
sequencing unaffected, carrier and affected individuals from 
the families, or performing genome-wide association studies 
(GWAS) in larger populations.
Since the first studies in which the genomic DNA of tumor 
and normal cells were sequenced (Ley et al. 2008) several 
international comprehensive cancer genomics projects (such 
as the Cancer Genomes Project, the Cancer Genome Atlas 
and the International Cancer Genome Consortium) have been 
initiated to identify new driver mutations and to examine 
the association between mutated genes and the efficiency of 
drugs. Based on their results more and more targeted therapies 
to treat patients have become available. GWAS are aimed to 
discover those genomic regions that are associated with a 
particular trait or disease and are based on the genotyping 
of larger populations of several hundred to several thousand 
individuals with and/or without the investigated trait (such 
as affected and healthy people) for a huge number (up to 
millions) of SNPs and structural variants. Variants that are 
more common or less common, for example, in the affected 
population may point towards the regions that carry risk or 
protective variants, respectively. Many structural variants 
were identified before the NGS era; however, the availability 
of the massively parallel sequencing technologies provides 
high-throughput support for the discovery of the struc-
tural variants. In 2008, the ambitious 1000 Genomes Project 
(http://www.1000genomes.org) was launched to create a 
very detailed catalogue of human genetic variation. The goal 
of the project is to find the most genetic variants that have 
frequencies of at least 1% in the populations studied. In the 
first, pilot phase of the project, whole genome sequencing 
of 180 samples and 2 mother-father-adult child trios were 
performed at 2-4-fold and 20-60-fold coverage, respectively 
(in average, every nucleotide of the genome was sequenced 
2-4 or 20-60 times) and the sequence of 1000 gene regions 
from 900 samples was determined at 50-fold coverage (The-
1000-Genomes-Project-Consortium 2010). To complete 
the sequencing part of the project, 2500 genomes will be 
sequenced at fourfold coverage.
Targeted genome re-sequencing 
There is growing interest in sequencing only specific por-
tions of genomes because targeted re-sequencing strategies 
provide an efficient and cost-effective solution to analyze 
these reduced genomes in a highly parallel way. These strate-
gies allow the systematic detection of germline and somatic 
mutations in cancer or disease associated regions as well 
as investigation of all type of structural variations having 
importance in basic or clinical research (Porreca et al. 2007; 
Choi et al. 2009; Biesecker 2010; Ng et al. 2010a; Ng et al. 
2010b). There are a wide variety of target enrichment meth-
ods offered for different NGS platforms, to sequence only a 
limited number of genes or even whole exomes (Gnirke et al. 
2009; Bodi et al. 2013; Lin et al. 2014), i.e. the transcribed 
part of all predicted genes. As the exome represents only l-2% 
of the human genome, even this reduction of the sequencing 
will significantly decrease the sequencing cost as compared 
to whole genome sequencing. 
Basically, the target enrichment methods are based on 
two techniques: PCR or hybridization. In the case of ampli-
con sequencing, which is used to investigate from a few to 
several hundred genomic regions across multiple samples, 
multiplex PCR amplifications are carried out with primers 
specific for the target sequences. An amplicon library can be 
prepared either by ligating the sequencing adapters to the PCR 
products or by adding the adapters during PCR amplification 
by designing PCR primers flanked by adaptors specific for 
the given sequencing platform to target the genomic regions 
of interest. The hybridization based methods fall into three 
classes: DNA-chip-based capture, DNA-probe-based solution 
hybridization, and RNA-probe-based solution hybridization. 
To perform the capture of the target sequence, genomic DNA 
is sheared and processed into a sequencing library specific 
to a given sequencing instrument. Library fragments are then 
subject of hybridization to long oligonucleotide probes spe-
cific for target regions that are either fixed to a solid surface or 
are biotin-labelled which can be bound to streptavidin-coated 
magnetic beads. After the hybridization step, the targeted re-
gions will be immobilized on the solid surface (chip, beads), 
while the non-target regions remain in the liquid phase and 
can be washed away. At the end, the library fragments are 
removed from the solid surface and will be sequenced.
Transcriptome sequencing 
Next-generation sequencing is a powerful tool to study the 
molecular mechanisms and regulation of gene transcription 
and to catalogue and discover novel transcripts and alterna-
tive spliced isoforms (Wang et al. 2009). It gives information 
about the transcriptional state and gene networks of cells 
via the quantification and comparison of gene expression 
levels under different developmental, physiological and en-
vironmental conditions. With the transcriptome sequencing 
approach, different RNA populations including mRNA and 
small RNAs such as miRNA, PIWI-interacting RNAs, small 
nucleolar RNAs, small interfering RNAs can be studied and 
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the genome annotation can be facilitated by the determina-
tion of the exon sequences. These advantages make RNA 
sequencing (RNA-Seq) an increasingly attractive method for 
whole-genome expression studies in many biological systems 
including species with unsequenced genomes.
Whole Transcriptome Analysis
Whole transcriptome analysis (WTA) via RNA-Seq is aimed 
to determine the abundance of each coding and non-coding 
transcripts in samples and enables the detection of genome-
wide gene expression changes across different environmental, 
physiological and developmental conditions as well as in 
different cell types, tissues, organs of an individual. Because 
of the high output of the second-generation NGS systems, 
transcriptome analysis by RNA-Seq is more sensitive, more 
specific and has higher dynamic range than the microarray 
based technology. In addition, at proper sequencing depth, it 
allows the detection of rare transcripts as well as novel and 
rare splice isoforms (Van Verk et al. 2013).
The quality of starting RNA material highly influences 
the success of an RNA-Seq experiment. The RNA quality 
can be measured by Bioanalyser (Agilent Technologies) 
which gives information about the integrity (RIN) of the 
RNA sample (ranging from 1-10, from degraded RNA sample 
to a high quality intact RNA, respectively) (Schroeder et 
al. 2006). Prior to sequence library preparation ribosomal 
RNAs (rRNAs) should be removed using a hybridization/
bead capture procedure - that selectively removes the rRNA 
molecules with the help of biotinylated capture probes - from 
the total RNA sample to enable the detection of less abun-
dant transcripts. The complexity of eukaryotic samples can 
be further decreased by capturing only those transcripts that 
have poly-adenyl tail. DNase treatment of the starting RNA 
material is important to avoid biases coming from genomic 
DNA contamination. Ribosomal RNA-depleted total RNA is 
fragmented and converted into cDNA containing the specific 
adaptors, PCR amplified and sequenced to produce sequence 
data from one or both end (paired-end) of the cDNA fragment. 
Finally, the sequencing reads are aligned to a reference ge-
nome and counted. Strand specific RNA-Seq protocols permit 
the detection of antisense transcripts derived from the other 
strands of the genes. Strand orientation provides information 
about regulatory relationships that would otherwise be missed 
and also provides increased confidence in transcript annota-
tion and may increase mapping efficiency. 
The third-generation SMRT sequencing technology ap-
plies an amplification-free protocol which overcomes the 
problem of PCR biases and enables a more even coverage of 
transcripts. Moreover, it sequences an entire RNA molecule 
from the 5′ to the 3′ end which makes feasible the deep 
sequencing of full-length RNAs from complex eukaryotic 
transcriptomes (Sharon et al. 2013). 
High-throughput SuperSAGE: Serial Analysis of 
Gene Expression using NGS
The Serial Analysis of Gene Expression (SAGE) method was 
developed based on the principles that (i) a short sequence tag 
of 15-20 nucleotide length can uniquely identify a transcript if 
the tag is obtained from a unique position of the transcript; (ii) 
the quantity of a particular tag provides the expression level 
of the corresponding transcript. As these short tags represent 
the transcripts, there is no need for WTA by RNA-Seq and in 
this way, the sequencing costs can be decreased considerably 
(Matsumura et al. 2010). Polyadenylated RNA molecules or 
originally non-polyadenylated RNAs, to which a polyadenyl 
tail was added are captured with biotinylated oligo-dT probes 
and are reverse transcribed into cDNA. The double-stranded 
cDNA molecules (still on the surface of the capturing beads) 
are digested with an anchoring enzyme recognizing four 
nucleotides (such as NlaIII, DpnII or BfaI) and a platform 
specific adapter carrying also the recognition sequence of 
the type III endonuclease EcoP15I of phage P1 next to the 
anchoring site is ligated to the digested anchored fragments. 
Then the adapter ligated fragments are digested with EcoP15I 
cleaving the DNA at a 25 bp distance and with the ligation of 
a second, barcoded sequencing adaptor and 3-10 PCR cycles, 
the library is constructed. After sequencing of the library, the 
reads are mapped one by one on the genome of interest and 
the transcripts are quantified providing an efficient way to 
construct differential expression profiles. The drawback of 
the method is that it is not so robust to detect rare mRNAs 
and as it targets the 3’ untranslated region of the transcripts 
fails to discover and survey splice variants. 
Small RNA Sequencing
In most organisms, small non-coding RNAs (sncRNAs) play 
important role in the transcriptional and post-transcriptional 
regulation of gene expression including the regulation of 
transposon and foreign DNA activity (e.g., miRNAs, siR-
NAs, tasiRNAs, piRNAs) as well as in the formation of the 
spliceosome complex (snRNAs) and in the methylation and 
pseudo-uridylation of other (such as ribosomal) RNAs (snoR-
NAs). The regulation of gene expression by the 18-30 nt long 
sncRNAs is achieved by silencing genes via complementary 
base pairing with target RNAs (Filipowicz et al. 2008). In this 
way, most cellular and even organism level processes, like 
developmental timing, cell differentiation, nutrient signaling 
and implicated in many diseases is regulated by sncRNAs. 
Small RNA-Seq allows the identification of already known 
and novel small RNAs, enables the investigation of their dif-
ferential expression among different samples by preserving 
strand specific information. Prior to sequencing small RNA 
enrichment is recommended. The library preparation work-
flow is the same as for WTA by RNA-Seq, the only difference 
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is that in the case of small RNAs there is no need for RNA 
fragmentation. 
Metagenomics
Metagenomics is a powerful tool for exploring and compar-
ing complex microbial communities in environmental or 
clinical samples and enables the study of yet uncharacterized 
microorganisms which cannot be cultivated in laboratory and 
represents the vast majority of environmental microbial com-
munities on Earth (Blainey 2013). All organisms including 
humans live in close association with microbial communities 
as part of an interdependent metaorganism. The collective 
genome of the microorganisms that reside in an environ-
mental niche, such as the human gut or skin, is called the 
microbiome. There are ~10 times more microbial cells (as 
part of different microbiomes) in (and on) a human body than 
human cells and the importance and impact of these commu-
nities on human physiology and health have been recognized 
recently. For example, the comparison of the microbiome 
from lean and obese twins revealed significant differences in 
the composition, diversity and biochemical potential of the 
communities (Turnbaugh et al. 2009).
A metagenomics project based on NGS technology can 
create a catalogue of microbial species that are present in a 
sample and determine what their ratio is or may survey the 
biochemical potential of the community in a very cost effec-
tive way. In addition, comparative metagenomic analysis of 
samples collected at different time points provides informa-
tion about the dynamics of the population. The determination 
of the identity and abundance of the microorganisms in the 
sample can be achieved by both 16S ribosomal RNA (16S 
rRNA) amplicon sequencing and shotgun whole genome 
sequencing approaches (Sanschagrin and Yergeau 2014). 
The most commonly used approach for investigating en-
vironmental prokaryotic diversity is the amplification and 
sequencing of the highly conserved phylogenetic marker, the 
16S rRNA gene. The 16S rRNA gene contains conservative 
and variable regions (Pereira et al. 2010) that can be used for 
designing primers to allow the PCR amplification and after 
sequencing the identification, respectively. The limitation of 
the 16S rRNA gene-based sequencing is the primer bias and 
that it detects the predominant members of the community 
but may not give information about the rare microbial spe-
cies because of the low sampling depth. To overcome these 
limitations, metagenome shotgun sequencing is performed, 
which targets all DNA that can be extracted from the sample. 
For this purpose, the extracted genomic DNA is randomly 
sheared into smaller fragments and a sequencing library 
specific for the NGS platform used is constructed. Depend-
ing on the sequencing depth, not only the composition of the 
population but also the gene content of the metaorganism 
can be determined. The challenges and limitations of whole 
metagenome strategies are the relatively large amounts of 
starting material needed, the high number of genes with 
unknown function and annotation and in the case of clinical 
samples, the potential contamination of metagenomic samples 
with host genetic material which lowers sequencing depth 
(Petrosino et al. 2009).
Beside the DNA-based metagenomics, the metatran-
scriptome of the microbial communities can also be studied. 
It can provide information about not only the composition 
of the population but also about the metabolic potential and 
dynamics of the community, how the microbial activities 
are regulated and respond to the environmental changes. 
For metatranscriptome analysis, the environmental RNA 
samples are converted to cDNA and sequencing platform 
specific libraries are constructed. For the determination of 
the composition of the microbial community, the removal 
of the ribosomal RNA population constituting >95% of the 
RNA pool is not necessary but for the investigation of actively 
transcribed genes, rRNA sequences are removed in order to 
get enough mRNA sequence reads.
Genome-wide mapping of DNA-protein 
interactions
Protein-DNA interactions play important role in the regulation 
of gene expression. Chromatin re-modelling is a dynamic pro-
cess driven by protein modifications that change DNA-protein 
interactions and alter DNA accessibility for transcriptional 
regulators (TFs: transcription factors) acting on specific se-
quences of the DNA. Histone proteins are the primary protein 
component of chromatin that compact chromosomal DNA. 
The basic structural and functional unit of chromatin is the 
nucleosome, which contains four basic proteins - H2A, H2B, 
H3, and H4 - forming an octamer and about 166 base pairs of 
DNA that is wrapped around the octamer. Posttranslational 
covalent modifications of histone tails such as methylation, 
acetylation, phosphorylation, ubiquitination and sumoylation 
are important epigenetic regulators of gene expression by 
determining DNA accessibility for TFs via maintaining an 
open or closed chromatin state (Campos and Reinberg 2009). 
Genome-wide mapping of histone modifications and tran-
scription factor-binding sites can be identified by chromatin 
immunoprecipitation coupled to NGS sequencing (ChIP-Seq) 
which has become a frequently used technique (Kharchenko 
et al. 2008; Valouev et al. 2008). 
In this technique, the DNA bound to a protein of interest 
is enriched by immunoprecipitation using specific antibodies 
raised against the native or antigen-tagged or post-transla-
tionally modified protein and the captured DNA is sequenced 
by NGS. Prior to ChIP-Seq cells or tissues are treated with 
a cross-linking agent like formaldehyde to covalently attach 
proteins to DNA. This is followed by cell lysis and fragmen-
tation of the DNA by enzymatic digestion or sonication to 
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approximately 250 bp pieces (a bit longer than the DNA on 
the nucleosome) and the complexes are immunoprecipitated 
with the specific antibodies. After immunoprecipitation the 
cross-links are reversed, the enriched DNA is purified and 
prepared for high-throughput sequencing by attaching the 
specific adaptor sequences. The ChIP-DNA is analyzed by 
NGS sequencing which permits comprehensive coverage and 
resolution even in the case of large genomes. The technical 
limitations of the method are the need for a specific antibody 
raised against the protein of interest and the specificity of 
the antibody. 
Genome-wide mapping of DNA methylation 
Epigenetic modifications like DNA methylation play an 
important role in gene regulation and chromatin remodeling 
and thereby, are crucial to normal development, differentia-
tion of distinct cell lineages of the organism. Methylation of 
cytosines is a covalent modification of DNA which usually 
occurs at the carbon-5 position of cytosine residues (5mC). 
Methylation of cytosine nucleotides in DNA are known to 
alter DNA accessibility and thus to repress gene transcription. 
In mammals, most cytosine methylation occurs at CpG dinu-
cleotides that often in so-called CpG islands that are regions 
with a high frequency of CpG sites. These CpG islands are 
often located upstream of promoters or within the gene body 
(Ehrlich et al. 1982). In plants, DNA methylation commonly 
occurs at cytosine bases in all sequence contexts: symmetric 
CG and CHG (in which H = A, T or C) and asymmetric CHH 
context (Henderson and Jacobsen 2007). Unlike in mam-
mals, DNA methylation in plants predominantly occurs on 
transposons and other repetitive DNA elements (Zhang et al. 
2006). There are two hypotheses how epigenetic modifica-
tions can regulate gene expression: i) DNA methylation can 
form a physical barrier for binding of transcription factors, 
ii) methyl-CpG-binding domain proteins (MBDs) can bind to 
methylated DNA and recruit chromatin remodeling proteins 
like histone deacetylases that can modify histones forming 
compact, inactive heterochromatin. There are other epigenetic 
modifications such as cytosine hydroxymethylation (5hmC) 
and adenine methylation on the carbon-6 position (m6A) but 
their exact function is not known.
The high-throughput detection of DNA modification 
has been available only for 5mC by bisulfite sequencing, 
but nowadays, the third-generation SMRT technology (dis-
cussed earlier) makes it possible to recognize other base 
modifications, too (Flusberg et al. 2010; Fang et al. 2012). 
Bisulfite sequencing is based on the sodium bisulfite cata-
lyzed chemical deamination of the unmethylated cytosine 
(C) residues to uracil (U) which is recognized as thymidine 
(T) by DNA polymerases used in the following steps while 
5mC residues are not converted and thus, are recognized as 
cytosines (Clark et al. 1994). During whole genome bisulfite 
sequencing (WGBS), either the library (SOLiD) or the DNA 
before library preparation (Illumina) are treated with bisulfite. 
After sequencing, reads are aligned to an in silico converted, 
modified reference genome sequence in which the cytosines 
are exchanged to thymidines and methylated bases are rec-
ognized as SNPs. To decrease sequencing costs, enrichment 
methods to isolate methylated DNA, which are based on 
DNA-protein interactions, have been developed. Methylated 
DNA immunoprecipitation sequencing (MeDIP-Seq) uses 
an antibody that was raised against 5mC residues (Weber et 
al. 2005; Ruike et al. 2010), while MBD-Seq employs the 
Methyl-CpG Binding Domain protein to bind methylated 
DNA (Brinkman et al. 2010; Serre et al. 2010) followed by 
the immunoprecipitation of the protein-DNA complex with 
specific anti-MBD antibody-conjugated beads.
Genome-wide mapping of DNA accessibility and 
chromatin structure
As discussed earlier, the dynamic process of chromatin re-
modelling plays an important role in transcriptional regula-
tion via changing the accessibility of different DNA regions 
(and thus, genes) for transcription factors. A number of dif-
ferent methods have been developed to map the position of 
nucleosome-bound and free DNA.
Micrococcal Nuclease sequencing
Micrococcal nuclease sequencing (MNase-Seq) relies on the 
characteristics of the enzyme to specifically digest those DNA 
sequences that are not protected by a protein such as the linker 
region of the chromatin between nucleosomes (Telford and 
Stewart 1989). Therefore, the positioning of the nucleosomes 
and non-histone DNA-binding proteins determines which 
DNA fragments are protected from digestion and, thus, 
released from the complex during library preparation and 
sequenced. The efficiency of MNase digestion depends on 
the degree of chromatin compaction, i.e. less compact chro-
matin is more easily digested by the enzyme. To perform 
MNase-Seq, chromatin substrates are prepared from isolated 
cell nuclei or permeabilized cells and are then treated with 
MNase which is followed by the purification of the DNA and 
library construction.
Assay for transposase-accessible chromatin 
using sequencing
The assay for transposase-accessible chromatin using se-
quencing (ATAC-Seq) also provides information about 
chromatin compaction, nucleosome positioning and maps 
the genomic location of DNA-binding proteins in regulatory 
regions (Buenrostro et al. 2013). The method is based on the 
direct in vitro transposition of a modified Tn5 transposon car-
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rying sequencing adaptor sequences into the native chromatin. 
Transposons can integrate only into the active regulatory 
elements where the chromatin is open. Sequencing reads are 
generated at locations of nucleosome-free, active regulatory 
regions and provide base-pair resolution of the open chroma-
tin regions in the genome.
Formaldehyde-assisted isolation of regulatory 
elements 
Formaldehyde-assisted isolation of regulatory elements 
(FAIRE-Seq) is an alternative method for the genome-wide 
detection of nucleosome-depleted, open chromatin regions 
that are associated with regulatory activity, i.e. promoters and 
transcriptional start sites (Giresi et al. 2007). The technique 
is based on differences in cross-linking efficiencies between 
nucleosome-bound DNA and nucleosome-depleted regions. 
In this method, DNA-protein complexes are cross-linked in 
vivo using formaldehyde and then the sample is lysed, soni-
cated and the DNA is extracted. During phenol/chloroform 
extraction, the DNA not cross-linked to protein will be recov-
ered in the aqueous phase, while the DNA covalently linked 
to proteins will become trapped between the organic and 
aqueous phase. Finally, a sequencing library is constructed 
from the DNA recovered from the aqueous phase. Sequenc-
ing provides information about regions of DNA that are not 
occupied by histones.
NGS in the clinical practice
NGS technologies have revolutionized our process of learning 
about the relationship between genetic variations and causes, 
pathogenesis, progression and prognosis of diseases. While 
NGS keeps broaden this knowledge and the technologies, 
methods are continuously improved and developed, sequenc-
ing (equipment and operational) costs continue to decline. 
These developments support the introduction of NGS tech-
nology into the clinical practice to facilitate personalized 
medicine (including bedside diagnosis, decision making on 
treatment, patient stratification, etc.). Indeed, on 19 November 
2013, the U.S. Food and Drug Administration (FDA) approved 
the use of the Illumina MiSeqDx platform for the diagnosis of 
cystic fibrosis and certain health insurance plans may cover 
NGS-based diagnostic investigations. In addition, clinics and 
diagnostic companies using NGS help decision making in a 
wide range of clinical environments by supporting activities 
such as pre-implantation genetic screening, non-invasive pre-
natal testing, the diagnosis of inherited diseases of single-gene 
etiology (Mendelian diseases), oncology mutation screening 
or HLA typing before transplantation.
The success of in vitro fertilization (IVF) is most often hin-
dered by chromosome aneuploidy, i.e. when the cells contain 
one or more chromosomes not in two copies. Most embryos 
with aneuploidy do not implant and those that do often lost by 
spontaneous abortion. Pre-implantation genetic screening by 
NGS allows the quick ploidy testing of all somatic and sexual 
chromosomes to select euploid embryos for implantation and, 
thus, to increase ongoing pregnancy rate and to enable single 
embryo transfers which decreases the number of high-risk 
multiple pregnancies. 
Fetal aneuploidy and other chromosomal aberrations af-
fect almost 1% of natural pregnancies, too, and their probabil-
ity increases with the age of the parents. Classical and even 
more recent prenatal tests such as karyotyping and chromo-
some microarrays, respectively, require an invasive process 
(chorionic villus sampling or amniocentesis) to obtain fetal 
cells which imposes risks to both the fetus and the mother. 
The discovery of intact fetal cells in the maternal blood and 
later the recognition that the fraction of fetal DNA in the ma-
ternal plasma cell-free DNA (cfDNA) can be as high as 15% 
have led to the development of non-invasive prenatal testing 
(NIPT) methods to detect chromosomal aneuploidies and 
even subchromosome abnormalities (Fan et al. 2008; Srini-
vasan et al. 2013). At present, commercially available NIPT 
services are based on Illumina short-read sequencing of the 
maternal plasma cfDNA and provide information about the 
gender of the fetus and about trisomies of chromosomes 21, 
18 and 13 leading to Down-, Edwards- and Patau-syndrome, 
respectively. By the improvement of the analysis tools, 
however, trisomies with lower probability (such as trisomy 
8 causing Warkany syndrome 2) or trisomies (like 16 or 9) 
often resulting in first-trimester miscarriage as well as chro-
mosomal microdeletion syndromes can be detected, too.
As mentioned earlier, there are over 10000 monogenic 
diseases that appear with very low to rather high frequencies; 
cystic fibrosis (CF), for example, affects about one out of 
every three thousand new-borns among people of Northern 
European ancestry. Genetic risk factors for certain tumors 
and for complex traits have also been discovered. Based 
on the available genetic information, there are a number of 
NGS based assays, for example, to identify the carriers and 
to confirm the diagnosis of CF or detect germ-line muta-
tions that predispose individuals to cancer such as the BRCA 
(Breast Cancer) gene mutations. There are more comprehen-
sive tests investigating high number of genes that are most 
appropriate for situations where the evaluation of multiple 
genetic markers may clarify or refine the diagnosis because 
the presenting set of symptoms and tests are inconclusive, 
there are a large number of candidate genes to evaluate, or 
the phenotype might indicate multiple genetic conditions. In 
oncology, sequencing oncogenes and tumor suppressors may 
identify mutations that are targeted with a specific therapy or 




Viruses and bacteria can cause serious outbreaks in any 
population and in even in major clinical centers. The quick re-
constitution of how a new strain evolved to cause an outbreak 
such as the Shiga-toxin producing E. coli strain in Germany 
in 2011 (Mellmann et al. 2011), or tracking the route of an 
infection, for example, by an antibiotic resistant strain in 
an NIH hospital (Snitkin et al. 2012) have become possible 
because of the NGS technology.
Acknowledgements
The publication of this review was supported by the European 
Union, co-financed by the European Social Fund, within the 
framework of “Practice-oriented, student-friendly moderniza-
tion of the biomedical education for strengthening the inter-
national competitiveness of the rural Hungarian universities” 
TÁMOP-4.1.1.C-13/1/KONV-2014-0001 project. Human 
exome sequencing at the Seqomics Ltd was co-financed by 
the European Union (FP7 program “Rational molecular As-
sessments and Innovative Drug Selection”; grant number: 
304810) and the Hungarian government (EU_BONUS_12-1
-2012-0034). The authors thank Alina Kereszt for preparing 
the figures.
references
Biesecker LG (2010) Exome sequencing makes medical 
genomics a reality. Nat Genet 42:13-14.
Blainey PC (2013) The future is now: single-cell genomics of 
bacteria and archaea. FEMS Microbiol Rev 37:407-427.
Bodi K, Perera AG, Adams PS, Bintzler D, Dewar K, Grove 
DS, Kieleczawa J, Lyons RH, Neubert TA, Noll AC, Singh 
S, Steen R, Zianni M (2013) Comparison of commercially 
available target enrichment methods for next-generation 
sequencing. J Biomol Tech 24:73-86.
Brinkman AB, Simmer F, Ma K, Kaan A, Zhu J, Stunnenberg 
HG (2010) Whole-genome DNA methylation profiling 
using MethylCap-seq. Methods 52:232-236.
Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf 
WJ (2013) Transposition of native chromatin for fast and 
sensitive epigenomic profiling of open chromatin, DNA-
binding proteins and nucleosome position. Nat Methods 
10:1213-1218.
Campos EI, Reinberg D (2009) Histones: annotating chro-
matin. Annu Rev Genet 43:559-599.
Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, Zumbo P, Nay-
ir A, Bakkaloglu A, Ozen S, Sanjad S, Nelson-Williams 
C, Farhi A, Mane S, Lifton RP (2009) Genetic diagnosis 
by whole exome capture and massively parallel DNA 
sequencing. Proc Natl Acad Sci USA 106:19096-19101.
Clark SJ, Harrison J, Paul CL, Frommer M (1994) High sen-
sitivity mapping of methylated cytosines. Nucleic Acids 
Res 22:2990-2997.
Clarke J, Wu HC, Jayasinghe L, Patel A, Reid S, Bayley H 
(2009) Continuous base identification for single-molecule 
nanopore DNA sequencing. Nat Nanotechnol 4:265-
270.
Drossman H, Luckey JA, Kostichka AJ, D’Cunha J, Smith 
LM (1990) High-speed separations of DNA sequenc-
ing reactions by capillary electrophoresis. Anal Chem 
62:900-903.
Ehrlich M, Gama-Sosa MA, Huang LH, Midgett RM, Kuo 
KC, McCune RA, Gehrke C (1982) Amount and distribu-
tion of 5-methylcytosine in human DNA from different 
types of tissues of cells. Nucleic Acids Res 10:2709-
2721.
Ekblom R, Wolf JB (2014) A field guide to whole-genome 
sequencing, assembly and annotation. Evol Appl 7:1026-
1042.
Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake 
SR (2008) Noninvasive diagnosis of fetal aneuploidy by 
shotgun sequencing DNA from maternal blood. Proc Natl 
Acad Sci USA 105:16266-16271. 
Fang G, Munera D, Friedman DI, Mandlik A, Chao MC, 
Banerjee O, Feng Z, Losic B, Mahajan MC, Jabado OJ, 
Deikus G, Clark TA, Luong K, Murray IA, Davis BM, 
Keren-Paz A, Chess A, Roberts RJ, Korlach J, Turner SW, 
Kumar V, Waldor MK, Schadt EE (2012) Genome-wide 
mapping of methylated adenine residues in pathogenic 
Escherichia coli using single-molecule real-time sequenc-
ing. Nat Biotechnol 30:1232-1239.
Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mech-
anisms of post-transcriptional regulation by microRNAs: 
are the answers in sight? Nat Rev Genet 9:102-114.
Flusberg BA, Webster DR, Lee JH, Travers KJ, Olivares EC, 
Clark TA, Korlach J, Turner SW (2010) Direct detection 
of DNA methylation during single-molecule, real-time 
sequencing. Nat Methods 7:461-465.
Gilbert W, Maxam A (1973) The nucleotide sequence of the 
lac operator. Proc Natl Acad Sci USA 70:3581-3584.
Giresi PG, Kim J, McDaniell RM, Iyer VR, Lieb JD (2007) 
FAIRE (Formaldehyde-Assisted Isolation of Regulatory 
Elements) isolates active regulatory elements from human 
chromatin. Genome Res 17:877-885.
Gnirke A, Melnikov A, Maguire J, Rogov P, LeProust EM, 
Brockman W, Fennell T, Giannoukos G, Fisher S, Russ 
C, Gabriel S, Jaffe DB, Lander ES, Nusbaum C (2009) 
Solution hybrid selection with ultra-long oligonucleotides 
for massively parallel targeted sequencing. Nat Biotechnol 
27:182-189.
Hall N (2007) Advanced sequencing technologies and their 
wider impact in microbiology. J Exp Biol 210:1518-
337
Next-Generation Sequencing in medicine
1525.
Henderson IR, Jacobsen SE (2007) Epigenetic inheritance in 
plants. Nature 447:418-424.
Hunyadkurti J, Feltoti Z, Horvath B, Nagymihaly M, Voros A, 
McDowell A, Patrick S, Urban E, Nagy I (2011) Complete 
genome sequence of Propionibacterium acnes type IB 
strain 6609. J Bacteriol 193:4561-4562.
International Human Genome Sequencing C (2001) Initial 
sequencing and analysis of the human genome. Nature 
409:860-921.
Jarvie T (2005) Next generation sequencing technologies. 
Drug Discov Today Technol 2:255-260.
Kharchenko PV, Tolstorukov MY, Park PJ (2008) Design 
and analysis of ChIP-seq experiments for DNA-binding 
proteins. Nat Biotechnol 26:1351-1359.
Korlach J, Bjornson KP, Chaudhuri BP, Cicero RL, Flusberg 
BA, Gray JJ, Holden D, Saxena R, Wegener J, Turner 
SW (2010) Real-time DNA sequencing from single poly-
merase molecules. Methods Enzymol 472:431-455.
Levene MJ, Korlach J, Turner SW, Foquet M, Craighead 
HG, Webb WW (2003) Zero-mode waveguides for sin-
gle-molecule analysis at high concentrations. Science 
299:682-686.
Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen 
K, Dooling D, Dunford-Shore BH, McGrath S, Hicken-
botham M, Cook L, Abbott R, Larson DE, Koboldt DC, 
Pohl C, Smith S, Hawkins A, Abbott S, Locke D, Hillier 
LW, Miner T, Fulton L, Magrini V, Wylie T, Glasscock J, 
Conyers J, Sander N, Shi X, Osborne JR, Minx P, Gordon 
D, Chinwalla A, Zhao Y, Ries RE, Payton JE, Westervelt P, 
Tomasson MH, Watson M, Baty J, Ivanovich J, Heath S, 
Shannon WD, Nagarajan R, Walter MJ, Link DC, Grau-
bert TA, DiPersio JF, Wilson RK (2008) DNA sequenc-
ing of a cytogenetically normal acute myeloid leukaemia 
genome. Nature 456:66-72.
Lin MT, Mosier SL, Thiess M, Beierl KF, Debeljak M, 
Tseng LH, Chen G, Yegnasubramanian S, Ho H, Cope 
L, Wheelan SJ, Gocke CD, Eshleman JR (2014) Clinical 
validation of KRAS, BRAF, and EGFR mutation detec-
tion using next-generation sequencing. Am J Clin Pathol 
141:856-866.
Macas J, Neumann P (2007) Ogre elements--a distinct group 
of plant Ty3/gypsy-like retrotransposons. Gene 390:108-
116.
Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, 
Bemben LA, Berka J, Braverman MS, Chen YJ, Chen Z, 
Dewell SB, Du L, Fierro JM, Gomes XV, Godwin BC, 
He W, Helgesen S, Ho CH, Irzyk GP, Jando SC, Alenquer 
ML, Jarvie TP, Jirage KB, Kim JB, Knight JR, Lanza JR, 
Leamon JH, Lefkowitz SM, Lei M, Li J, Lohman KL, 
Lu H, Makhijani VB, McDade KE, McKenna MP, Myers 
EW, Nickerson E, Nobile JR, Plant R, Puc BP, Ronan MT, 
Roth GT, Sarkis GJ, Simons JF, Simpson JW, Srinivasan 
M, Tartaro KR, Tomasz A, Vogt KA, Volkmer GA, Wang 
SH, Wang Y, Weiner MP, Yu P, Begley RF, Rothberg JM 
(2005) Genome sequencing in microfabricated high-
density picolitre reactors. Nature 437:376-380.
Marx V (2013) Next-generation sequencing: The genome 
jigsaw. Nature 501:263-268.
Matsumura H, Yoshida K, Luo S, Kimura E, Fujibe T, Al-
bertyn Z, Barrero RA, Kruger DH, Kahl G, Schroth GP, 
Terauchi R (2010) High-throughput SuperSAGE for 
digital gene expression analysis of multiple samples using 
next generation sequencing. PLoS One 5:e12010.
Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold 
SR, Rico A, Prior K, Szczepanowski R, Ji Y, Zhang W, 
McLaughlin SF, Henkhaus JK, Leopold B, Bielaszewska 
M, Prager R, Brzoska PM, Moore RL, Guenther S, Roth-
berg JM, Karch H (2011) Prospective genomic character-
ization of the German enterohemorrhagic Escherichia coli 
O104:H4 outbreak by rapid next generation sequencing 
technology. PLoS One 6:e22751.
Metzker ML (2010) Sequencing technologies - the next gen-
eration. Nat Rev Genet 11:31-46.
Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, Mc-
Millin MJ, Gildersleeve HI, Beck AE, Tabor HK, Cooper 
GM, Mefford HC, Lee C, Turner EH, Smith JD, Rieder 
MJ, Yoshiura K, Matsumoto N, Ohta T, Niikawa N, 
Nickerson DA, Bamshad MJ, Shendure J (2010a) Exome 
sequencing identifies MLL2 mutations as a cause of Ka-
buki syndrome. Nat Genet 42:790-793.
Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, 
Dent KM, Huff CD, Shannon PT, Jabs EW, Nickerson 
DA, Shendure J, Bamshad MJ (2010b) Exome sequencing 
identifies the cause of a mendelian disorder. Nat Genet 
42:30-35.
Pereira F, Carneiro J, Matthiesen R, van Asch B, Pinto N, 
Gusmao L, Amorim A (2010) Identification of species by 
multiplex analysis of variable-length sequences. Nucleic 
Acids Res 38:e203.
Petrosino JF, Highlander S, Luna RA, Gibbs RA, Versalovic 
J (2009) Metagenomic pyrosequencing and microbial 
identification. Clin Chem 55:856-866.
Porreca GJ, Zhang K, Li JB, Xie B, Austin D, Vassallo SL, 
LeProust EM, Peck BJ, Emig CJ, Dahl F, Gao Y, Church 
GM, Shendure J (2007) Multiplex amplification of large 
sets of human exons. Nat Methods 4:931-936.
Ruike Y, Imanaka Y, Sato F, Shimizu K, Tsujimoto G (2010) 
Genome-wide analysis of aberrant methylation in human 
breast cancer cells using methyl-DNA immunoprecipita-
tion combined with high-throughput sequencing. BMC 
Genomics 11:137.
Sanger F, Air GM, Barrell BG, Brown NL, Coulson AR, Fid-
des CA, Hutchison CA, Slocombe PM, Smith M (1977) 




Sanger F, Coulson AR (1975) A rapid method for determin-
ing sequences in DNA by primed synthesis with DNA 
polymerase. J Mol Biol 94:441-448.
Sanschagrin S, Yergeau E (2014) Next-generation sequenc-
ing of 16S ribosomal RNA gene amplicons. J Vis Exp 
90:e51709, Doi: 10.3791/51709.
Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber 
M, Gassmann M, Lightfoot S, Menzel W, Granzow M, 
Ragg T (2006) The RIN: an RNA integrity number for 
assigning integrity values to RNA measurements. BMC 
Mol Biol 7:3.
Serre D, Lee BH, Ting AH (2010) MBD-isolated Genome 
Sequencing provides a high-throughput and comprehen-
sive survey of DNA methylation in the human genome. 
Nucleic Acids Res 38:391-399.
Sharon D, Tilgner H, Grubert F, Snyder M (2013) A single-
molecule long-read survey of the human transcriptome. 
Nat Biotechnol 31:1009-1014.
Smith LM, Sanders JZ, Kaiser RJ, Hughes P, Dodd C, Connell 
CR, Heiner C, Kent SB, Hood LE (1986) Fluorescence 
detection in automated DNA sequence analysis. Nature 
321:674-679.
Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Group NCSP, 
Henderson DK, Palmore TN, Segre JA (2012) Tracking 
a hospital outbreak of carbapenem-resistant Klebsiella 
pneumoniae with whole-genome sequencing. Sci Transl 
Med 4:148ra116.
Srinivasan A, Bianchi DW, Huang H, Sehnert AJ, Rava RP 
(2013) Noninvasive detection of fetal subchromosome 
abnormalities via deep sequencing of maternal plasma. 
Am J Hum Genet 92:167-176.
Telford DJ, Stewart BW (1989) Micrococcal nuclease: its 
specificity and use for chromatin analysis. Int J Biochem 
21:127-137.
The-1000-Genomes-Project-Consortium (2010) A map of hu-
man genome variation from population-scale sequencing. 
Nature 467:1061-1073.
Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Dun-
can A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit 
JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon 
JI (2009) A core gut microbiome in obese and lean twins. 
Nature 457:480-484.
Valouev A, Johnson DS, Sundquist A, Medina C, Anton E, 
Batzoglou S, Myers RM, Sidow A (2008) Genome-wide 
analysis of transcription factor binding sites based on 
ChIP-Seq data. Nat Methods 5:829-834.
Van Verk MC, Hickman R, Pieterse CM, Van Wees SC (2013) 
RNA-Seq: revelation of the messengers. Trends Plant Sci 
18:175-179.
Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton 
GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne 
JD, Amanatides P, Ballew RM, Huson DH, Wortman JR, 
Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, 
Subramanian G, Thomas PD, Zhang J, Gabor Miklos GL, 
Nelson C, Broder S, Clark AG, Nadeau J, McKusick VA, 
Zinder N, Levine AJ, Roberts RJ, Simon M, Slayman C, 
Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, 
Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz 
S, Levy S, Mobarry C, Reinert K, Remington K, Abu-
Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, 
Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi 
K, Deng Z, Di Francesco V, Dunn P, Eilbeck K, Evangelis-
ta C, Gabrielian AE, Gan W, Ge W, Gong F, Gu Z, Guan P, 
Heiman TJ, Higgins ME, Ji RR, Ke Z, Ketchum KA, Lai 
Z, Lei Y, Li Z, Li J, Liang Y, Lin X, Lu F, Merkulov GV, 
Milshina N, Moore HM, Naik AK, Narayan VA, Neelam 
B, Nusskern D, Rusch DB, Salzberg S, Shao W, Shue B, 
Sun J, Wang Z, Wang A, Wang X, Wang J, Wei M, Wides 
R, Xiao C, Yan C, Yao A, Ye J, Zhan M, Zhang W, Zhang 
H, Zhao Q, Zheng L, Zhong F, Zhong W, Zhu S, Zhao S, 
Gilbert D, Baumhueter S, Spier G, Carter C, Cravchik A, 
Woodage T, Ali F, An H, Awe A, Baldwin D, Baden H, 
Barnstead M, Barrow I, Beeson K, Busam D, Carver A, 
Center A, Cheng ML, Curry L, Danaher S, Davenport L, 
Desilets R, Dietz S, Dodson K, Doup L, Ferriera S, Garg 
N, Gluecksmann A, Hart B, Haynes J, Haynes C, Heiner 
C, Hladun S, Hostin D, Houck J, Howland T, Ibegwam C, 
Johnson J, Kalush F, Kline L, Koduru S, Love A, Mann 
F, May D, McCawley S, McIntosh T, McMullen I, Moy 
M, Moy L, Murphy B, Nelson K, Pfannkoch C, Pratts 
E, Puri V, Qureshi H, Reardon M, Rodriguez R, Rogers 
YH, Romblad D, Ruhfel B, Scott R, Sitter C, Smallwood 
M, Stewart E, Strong R, Suh E, Thomas R, Tint NN, Tse 
S, Vech C, Wang G, Wetter J, Williams S, Williams M, 
Windsor S, Winn-Deen E, Wolfe K, Zaveri J, Zaveri K, 
Abril JF, Guigo R, Campbell MJ, Sjolander KV, Karlak B, 
Kejariwal A, Mi H, Lazareva B, Hatton T, Narechania A, 
Diemer K, Muruganujan A, Guo N, Sato S, Bafna V, Istrail 
S, Lippert R, Schwartz R, Walenz B, Yooseph S, Allen D, 
Basu A, Baxendale J, Blick L, Caminha M, Carnes-Stine 
J, Caulk P, Chiang YH, Coyne M, Dahlke C, Mays A, 
Dombroski M, Donnelly M, Ely D, Esparham S, Fosler C, 
Gire H, Glanowski S, Glasser K, Glodek A, Gorokhov M, 
Graham K, Gropman B, Harris M, Heil J, Henderson S, 
Hoover J, Jennings D, Jordan C, Jordan J, Kasha J, Kagan 
L, Kraft C, Levitsky A, Lewis M, Liu X, Lopez J, Ma D, 
Majoros W, McDaniel J, Murphy S, Newman M, Nguyen 
T, Nguyen N, Nodell M, Pan S, Peck J, Peterson M, Rowe 
W, Sanders R, Scott J, Simpson M, Smith T, Sprague A, 
Stockwell T, Turner R, Venter E, Wang M, Wen M, Wu D, 
Wu M, Xia A, Zandieh A, Zhu X (2001) The sequence of 
the human genome. Science 291:1304-1351.
Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: a revolu-
tionary tool for transcriptomics. Nat Rev Genet 10:57-
63.
Watson JD, Crick FH (1953) Molecular structure of nucleic 
339
Next-Generation Sequencing in medicine
acids; a structure for deoxyribose nucleic acid. Nature 
171:737-738.
Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam 
WL, Schubeler D (2005) Chromosome-wide and pro-
moter-specific analyses identify sites of differential DNA 
methylation in normal and transformed human cells. Nat 
Genet 37:853-862.
Wetzel J, Kingsford C, Pop M (2011) Assessing the benefits of 
using mate-pairs to resolve repeats in de novo short-read 
prokaryotic assemblies. BMC Bioinformatics 12:95.
Wu R, Taylor E (1971) Nucleotide sequence analysis of DNA. 
II. Complete nucleotide sequence of the cohesive ends of 
bacteriophage lambda DNA. J Mol Biol 57:491-511.
Zhang X, Yazaki J, Sundaresan A, Cokus S, Chan SW, Chen 
H, Henderson IR, Shinn P, Pellegrini M, Jacobsen SE, 
Ecker JR (2006) Genome-wide high-resolution mapping 
and functional analysis of DNA methylation in Arabidop-
sis. Cell 126:1189-1201.
Author recommended web-resources
Manufacturers constructed videos explaining the sequencing 
technologies in detail:
https://www.youtube.com/watch?v=rsJoG-AulNE
https://www.youtube.com/watch?v=WYBzbxIfuKs
https://www.youtube.com/watch?v=womKfikWlxM
https://www.youtube.com/watch?v=nlvyF8bFDwM
https://www.youtube.com/watch?v=NHCJ8PtYCFc
https://www.youtube.com/watch?v=3UHw22hBpAk

